Brief Description of the Company
Since 1964, NOBEL is one of the leading pharmaceutical companies in Turkey, with successful marketing and sales strategies, supported by a vertical integration of developing and manufacturing pharmaceuticals. NOBEL is backed up by the two major manufacturing companies of the group including ULKAR KİMYA and NOBELFARMA. ULKAR KİMYA is dedicated to active pharmaceutical ingredients and controlled release micro pellets, whereas NOBELFARMA is active in pharmaceutical finished dosage forms. NOBEL’s dynamism and flexibility enable NOBEL to set-up new strategies in accordance with the fast changing market conditions in Turkey and the developing markets including Central Asia, Eastern Europe and the CIS.
The products manufactured and marketed within the group cover the following therapeutic areas:
Analgesics-antipyretics, anti-inflammatory and anti-rheumatics, anti-infectives, anti-allergics, cardiovascular system products, cold and cough products, gastrointestinal system products, genitourinary products, oncology products, psychotherapeutics, respiratory system products
The company’s product range also comprises vitamins and minerals, dermo-cosmetics, dietary supplements, sterile, unit-dose saline solution for nasal and ophthalmic use
NOBEL is also active in the field of biotechnological and biosimilar products, by co-development and in-licensing.
63,000 sqm closed area
Annual Production Capacity
Solid Products: 102 million packs
Semi-solid Products: 3 million packs
Liquid Products: 16 million packs
Injectable Products: 15 million packs
Turkey, Germany, Ukraine, Bulgaria
ISO-9001:2008, ISO-14001:2004 by the TÜV CERT
Number of Employees